Exosome-Based Therapeutics Development Summit

NorthX Biologics will participate in the 7th Exosome-Based Therapeutics Development Summit, taking place in Boston, MA, from September 23–25, 2025. Our involvement will highlight the company’s role in advancing exosome and EV-based therapies, alongside other industry leaders focused on clinical translation and scalable manufacturing.

We hope to see you there!

When: September 23-25, 2025
Where: Boston, MA, USA

Read more about the event here.

If you are interested in booking a meeting in advance, please fill out the form here.

About NorthX Biologics AB

NorthX Biologics is a CDMO and Innovation Hub in Advanced Biologics, with +30 years of GMP production experience. The team provides process development and GMP manufacturing services with expertise in plasmid DNA, mRNA, proteins, cells and other advanced biologics. Headquartered in the heart of Sweden, the team serves customers worldwide and in 2021 was recognized as a national innovation hub for advanced therapeutics and vaccines. NorthX Biologics has the ambition to become a leading cell and gene therapy manufacturer and partner of choice for innovative drug development companies.

For more news, follow us on LinkedIn